These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 16712667

  • 1. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
    Gannagé-Yared MH, Fares F, Semaan M, Khalife S, Jambart S.
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
    [Abstract] [Full Text] [Related]

  • 2. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity.
    Kim SM, Lee J, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):594-8. PubMed ID: 16268814
    [Abstract] [Full Text] [Related]

  • 3. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men.
    Gannagé-Yared MH, Khalife S, Semaan M, Fares F, Jambart S, Halaby G.
    Eur J Endocrinol; 2006 Jul; 155(1):167-76. PubMed ID: 16793964
    [Abstract] [Full Text] [Related]

  • 4. Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.
    Gannagé-Yared MH, Azar RR, Amm-Azar M, Khalifé S, Germanos-Haddad M, Neemtallah R, Halaby G.
    Metabolism; 2005 Jul; 54(7):947-51. PubMed ID: 15988706
    [Abstract] [Full Text] [Related]

  • 5. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
    Ashley DT, O'Sullivan EP, Davenport C, Devlin N, Crowley RK, McCaffrey N, Moyna NM, Smith D, O'Gorman DJ.
    Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
    [Abstract] [Full Text] [Related]

  • 6. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B, Iorio S, Molinari A, Giustina A, Carella C.
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [Abstract] [Full Text] [Related]

  • 7. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [Abstract] [Full Text] [Related]

  • 8. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J, McQuillan BM, Thompson PL, Beilby JP.
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [Abstract] [Full Text] [Related]

  • 9. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL, Elofsson S, Brismar K.
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [Abstract] [Full Text] [Related]

  • 10. The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity.
    Ugur-Altun B, Altun A, Gerenli M, Tugrul A.
    Diabetes Res Clin Pract; 2005 Jun; 68(3):217-22. PubMed ID: 15936463
    [Abstract] [Full Text] [Related]

  • 11. Do sex hormones influence features of the metabolic syndrome in middle-aged women? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study.
    Shakir YA, Samsioe G, Nyberg P, Lidfeldt J, Nerbrand C, Agardh CD.
    Fertil Steril; 2007 Jul; 88(1):163-71. PubMed ID: 17383645
    [Abstract] [Full Text] [Related]

  • 12. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
    Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
    [Abstract] [Full Text] [Related]

  • 13. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia.
    Inoue M, Yano M, Yamakado M, Maehata E, Suzuki S.
    Metabolism; 2006 Sep; 55(9):1248-54. PubMed ID: 16919546
    [Abstract] [Full Text] [Related]

  • 14. Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women.
    Uemura H, Yasui T, Miyatani Y, Yamada M, Hiyoshi M, Arisawa K, Irahara M.
    Menopause; 2008 Sep; 15(1):180-4. PubMed ID: 17545921
    [Abstract] [Full Text] [Related]

  • 15. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations.
    Yasui T, Tomita J, Miyatani Y, Yamada M, Uemura H, Irahara M, Arai M, Kojimahara N, Okabe R, Ishii Y, Tashiro S, Sato H.
    Clin Chim Acta; 2007 Sep; 386(1-2):69-75. PubMed ID: 17825805
    [Abstract] [Full Text] [Related]

  • 16. Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome.
    Setola E, Monti LD, Lucotti P, Galluccio E, Oldani M, Bosi E, Piatti P.
    Diabetes Metab Res Rev; 2009 Oct; 25(7):639-46. PubMed ID: 19685554
    [Abstract] [Full Text] [Related]

  • 17. Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children.
    Chu NF, Shen MH, Wu DM, Lai CJ.
    Obes Res; 2005 Nov; 13(11):2014-20. PubMed ID: 16339134
    [Abstract] [Full Text] [Related]

  • 18. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.
    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):75-80. PubMed ID: 15212647
    [Abstract] [Full Text] [Related]

  • 19. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, De la Vega-Prieto MJ, Milena-Abril A, Sánchez-Pérez MJ, Martínez-Riera A, Gómez-Rodríguez Mde L.
    Alcohol Alcohol; 2006 Jul; 41(3):261-6. PubMed ID: 16476762
    [Abstract] [Full Text] [Related]

  • 20. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA.
    Climacteric; 2008 Jul; 11(6):509-17. PubMed ID: 18991078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.